- Home
- ORMP vs LUCD Comparison
ORMP vs LUCD Comparison
Compare ORMP & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | LUCD |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 190.8M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ORMP | LUCD |
|---|---|---|
| Price | $4.11 | $1.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 516.0K | ★ 1.7M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | 16.67 |
| EPS | ★ 0.91 | N/A |
| Revenue | $2,000,000.00 | ★ $4,346,000.00 |
| Revenue This Year | N/A | $115.58 |
| Revenue Next Year | N/A | $130.54 |
| P/E Ratio | $4.45 | ★ N/A |
| Revenue Growth | 49.25 | ★ 79.00 |
| 52 Week Low | $1.98 | $0.90 |
| 52 Week High | $5.19 | $1.63 |
Technical Indicators
Market Signals| Indicator | ORMP | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 47.66 | 48.78 |
| Support Level | $3.69 | $0.99 |
| Resistance Level | $4.22 | $1.11 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 16.67 | 25.05 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.